Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Honduras - Press Releases
- 7029 Press Releases ยท
- RSS
Published on Thu 6 Mar 2025 4:48:28 UTC
Wallbox anuncia la disponibilidad de pedidos anticipados del cargador bidireccional Quasar 2 para el SUV insignia
Published on Thu 6 Mar 2025 4:48:24 UTC
CHARLOTTE, N.C., March 5, 2025 /PRNewswire/ -- From being a scooper at his local Ben & Jerry's to a visionary CEO, Antonio McBroom embarks on his next venture with the launch of his first publicly released book: The Self-ish Servant: Inspirational Lessons from a Visionary CEO to Create Extra-Ordinary Life. Offering an innovative framework for leadership that combines self-development with servant leadership principles, The Self-ish Servantis available today on Amazon, Barnes & Noble and other major online booksellers.
Published on Thu 6 Mar 2025 4:48:21 UTC
ATLANTA, 5 de marzo de 2025 /PRNewswire-HISPANIC PR WIRE/-- The Home Depot, el mayor minorista de mejoras para el hogar del mundo, ha anunciado hoy que Michael Rowe ha sido designado vicepresidente ejecutivo (EVP, por sus siglas en ingls) de Pro, con efecto inmediato. Stephanie Smith ha sido ascendida a vicepresidenta ejecutiva y suceder a Tim Hourigan como vicepresidenta ejecutiva de Recursos Humanos, luego de la jubilacin de este, el 6 de junio, despus de casi 23 aos de servicio dedicado a la empresa.
Published on Thu 6 Mar 2025 4:48:14 UTC
CLGS is the Center for LGBTQ and Gender Studies at PSR
Published on Thu 6 Mar 2025 4:48:08 UTC
As respiratory season winds down, survey highlights need for continued education
Published on Thu 6 Mar 2025 4:48:03 UTC
Venture Capitalist Tracy Gray Aims to Address Women's Wealth Gap and Access to Capital
Published on Thu 6 Mar 2025 4:47:56 UTC
Fourth quarter Adjusted EBITDA1of $428million and full year Adjusted EBITDA of $1,690 million
Published on Thu 6 Mar 2025 4:47:52 UTC
Fourth quarter Adjusted EBITDA1of $428million and full year Adjusted EBITDA of $1,690 million
Published on Thu 6 Mar 2025 4:47:37 UTC
Milestone Commemorated with Savings for Prep and Exam Purchases
Published on Thu 6 Mar 2025 4:47:28 UTC
PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.
Published on Thu 6 Mar 2025 4:47:25 UTC
-Ascend Advanced Therapies nombra a John Chiminski como presidente y a Karen Flynn como directora independiente
Published on Thu 6 Mar 2025 4:47:20 UTC
NEW YORK, March 5, 2025 /PRNewswire/ --Lucid Diagnostics Inc.(Nasdaq: LUCD)("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced registered direct offering of 13,939,331 shares of common stock at a purchase price of $1.10 per share.
Published on Thu 6 Mar 2025 4:47:16 UTC
Tampa General Hospital Cancer Institute hosted a day of keynotes, presentations and discussions at TGH Brooksville to address the challenges facing cancer patients in rural communities.
Published on Thu 6 Mar 2025 4:47:07 UTC
CHICAGO, March 5, 2025 /PRNewswire/ -- TheRobert Spadoni Scholarship for Entrepreneurs is now accepting applications from undergraduate students nationwide who demonstrate exceptional entrepreneurial potential. Established by healthcare executive Robert Spadoni, this $1,000 scholarship supports students committed to creating positive change through entrepreneurial ventures.
Published on Thu 6 Mar 2025 4:47:06 UTC
DURHAM, N.C., March 5, 2025 /PRNewswire/ --Pluto Health, a Duke-University spin-out, is now a qualified Medicaid provider in TN. The company integrates care delivery with its proprietary platform that leverages AI and data science to deliver convenient care options and health services for patients. This milestone strengthens Pluto Health's commitment to delivering comprehensive, accessible, and high-quality care to patients across the state, particularly those in underserved communities.
Published on Thu 6 Mar 2025 4:47:03 UTC
WASHINGTON, March 5, 2025 /PRNewswire/ --Paralyzed Veterans of AmericaChief Executive Officer Carl Blake releases statement following the leak of an internal memorevealing the Department of Veterans Affairs' plan to reduce its overall staffing of the department to FY 2019 levels - a decrease of more than 80,000 positions from the current staffing level.
Published on Thu 6 Mar 2025 4:46:59 UTC
With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expanding. Despite competition from CAR-T and novel therapies, XPOVIO's oral administration and unique mechanism offer differentiation.
Published on Thu 6 Mar 2025 4:46:57 UTC
The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and development of innovative interferon therapies are key factors fueling the expansion of the interferon market from 2025 to 2032.
Published on Thu 6 Mar 2025 4:46:55 UTC
SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
Published on Thu 6 Mar 2025 4:46:52 UTC
The rising prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and cancer is greatly boosting the demand for biosensors, as these conditions necessitate frequent monitoring for proper management. Likewise, the increasing need for point-of-care testing (POCT) is propelling market growth, as biosensors offer fast and convenient diagnostic solutions beyond conventional healthcare facilities.
Published on Thu 6 Mar 2025 4:46:48 UTC
MINNEAPOLIS, March 5, 2025 /PRNewswire/ -- People who take over-the-counter pain relievers after a concussion may recover faster than those who do not take pain relievers, according to a preliminary study released March 5, 2025, that will be presented at the American Academy of Neurology's 77th Annual Meeting taking place April 5-9, 2025, in San Diego and online.
Published on Thu 6 Mar 2025 4:46:46 UTC
-Drugs found to be safe and effective overall despite some risk of eye damage
Published on Thu 6 Mar 2025 4:46:43 UTC
No Shareholder Action Required at this Time
Published on Thu 6 Mar 2025 4:46:40 UTC
SUZHOU, China, March 5, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Phase Ib clinical trial application in Australia for CS5001, its ROR1-targeting antibody-drug conjugate (ADC), in combination with first-line standard-of-care (SoC) for DLBCL. CS5001 is also being evaluated as both a monotherapy and in combination with a PD-L1 inhibitor for advanced solid tumors in an ongoing global multi-center clinical trial.
Published on Thu 6 Mar 2025 4:46:39 UTC
HONG KONG, March 5, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical trial (COMPASSION-22/AK104-306) evaluating cadonilimab, the world's first PD-1/CTLA-4 bispecific antibody independently developed by the company, as an adjuvant treatment for hepatocellular carcinoma (HCC) with high recurrence risk following curative resection or ablation.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities